Origen de la red de primer grado Mark H. Pavao.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Mark H. Pavao a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Goldman Sachs International
Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity | |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | President | |
Anchorage Capital Group LLC
Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group LLC is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Kevin Ulrich in 2003 as Anchorage Advisors LLC. They are a subsidiary of Anchorage Advisors Management LLC. Anchorage Capital Group provides investment advisory services to private investment funds and structured credit vehicles. | Investment Managers | Director/Board Member | |
CARA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
ZEVRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
University of Virginia | College/University | Undergraduate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity | |
Susquehanna University | College/University | Undergraduate Degree | |
Villanova University | College/University | Undergraduate Degree | |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Chief Executive Officer | |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology West-Ward Pharmaceutical Corp. provides generic prescription medication services. It offers both oral solid and injectable pharmaceuticals to chain stores, wholesalers, distributors, health systems and government agencies. The company is headquartered in Eatontown, US. | Pharmaceuticals: Major | Director of Finance/CFO | |
NEXGEL, INC. | Chemicals: Specialty | Director of Finance/CFO | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin | |
The Fuqua School of Business | College/University | Masters Business Admin | |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Nautilus Subsidiary, Inc.
Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Nautilus Biotechnology, Inc. operates as a biopharmaceutical company. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in San Carlos, CA. | Information Technology Services | Director/Board Member | |
NAUTILUS BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Biotechnology | Director/Board Member | |
The Andalusia Foundation | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 23 |
Reino Unido | 4 |
Sectorial
Health Technology | 14 |
Consumer Services | 6 |
Finance | 4 |
Retail Trade | 2 |
Process Industries | 2 |
Operativa
Director/Board Member | 11 |
Director of Finance/CFO | 7 |
Independent Dir/Board Member | 6 |
Comptroller/Controller/Auditor | 4 |
President | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Mark H. Pavao
- Conexiones Empresas